Functional Brain Mechanisms Underlying the Anti-suicidal Effects of Buprenorphine in Opioid Use Disorder
Functional Brain Mechanisms Underlying the Anti-Suicidal Effects of Buprenorphine in Opioid Use Disorder
Sponsor: Columbia University
Enrolling: Male and Female Patients
Study Length: 3 Weeks
IRB Number: 7855
U.S. Govt. ID: NCT04234516
Contact: Dr. Mina Rizk: 646-774-7518 /
Additional Study Information: This research study uses MRI scans to compare the effect of two medications on suicidal thoughts and brain activity in people who have opioid use disorder. We hope to develop a better understanding of how well these two medications help depression and suicidal thoughts. You may qualify if you have opioid use disorder and suicidal thoughts. Participation involves a detailed diagnostic set of interviews, brain imaging scans (MRI), and neuropsychological tasks. Eligible individuals will be hospitalized and receive free medication-based treatments for the duration of the study (3 weeks).
This study is closed
Mina Rizk, MD
Do You Qualify?
Are you between the ages 18-65 years? Yes No
Do you currently have opioid use disorder? Yes No
Are you seeking treatment for opioid use disorder and willing to be stabilized on buprenorphine when the study is over? Yes No
Do you have active suicidal thoughts? Yes No
Are you currently pregnant, breastfeeding, or trying to become pregnant? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Dr. Mina Rizk